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Isoquinolines and tetrahydroisoquinolines are important class of 
heterocycles due to their presence in a wide range of naturally 
occurring compounds. Isoquinoline derivatives exhibit various 
biological activities,1 including anti-HIV,2 antimalarial,3 ion-
channel blocking activity,4 act as dopamine agonists,5 and are 
present in some alkaloids.6 Pyridyl-substituted isoquinolines 
are of wide use as ligands for copper,7 as chiral catalysts8 and 
phosphorescent emitters for OLEDs.9 Traditional synthetic routes 
to isoquinolines are the Bischler–Napieralski, Pomeranz–Fritsch 
and Pictet–Spengler reactions, which involve the intramolecular 
cyclization under the drastic conditions.10 Pyridyl-substituted 
iso quinolines can also be accessed by cross-coupling reactions,11 
reactions mediated by organolithium compounds,12 as well as some 
heterocyclization reactions.13 In addition, some new synthetic 
approaches to isoquinolines appeared in a literature, especially 
due to the development of metal-catalyzed organic synthesis14 as 
well as modern aryne chemistry.15 Thus, an efficient synthesis of 
isoquinolines from alkynes and iododiimines and ketimines,16 as 
well as palladium-catalyzed aryne annulation with ortho-halo-
aldimines affording isoquinolines17 were reported. Recently18 
we described the synthesis of pyridyl-substituted isoquinolines 
using non-catalyzed cycloaddition of substituted 1,2,4-triazines 
and arynes generated in situ.
Herein we propose a rational protocol for the synthesis of 
pyridyl-substituted isoquinolines by the inverse demand Diels–
Alder reaction of 1,2,4-triazines (Scheme 1). The first precedent 
of such a reaction was reported19 in 1969 and nowadays this 
approach is of high demand.20 However, the inverse demand 
Diels–Alder reactions have never been used for the preparation 
of pyridyl-substituted isoquinolines.
Starting 1,2,4-triazines 3 were synthesized by described21 cyclo-
con densa tion between the corresponding amidrazones and dicar-
bonyl compounds or between isonitrosoacetophenone hydrazones 
and pyridine-2-carboxaldehyde. Our investigations began with 
examining the reaction conditions for preparing tetrahydroiso-
quinolines. According to the published data, various dienes can 
be efficiently applied for obtaining pyridine derivatives from 
1,2,4-triazines. In most cases 1,2,4-triazines and enamines of 
pyrrolidine22 were utilized to prepare the corresponding pyrido-
cyclopentenes. Only in a very few cases 1-morpholinocyclo-
hexene was used for similar purposes.23
We found that in case of enamine as the dienophile the product 
yield depended on the reactant ratio and the reaction temperature. 
Thus, refluxing of corresponding 1,2,4-triazines and 1 to 5 equiv. 
of 1-morpholinocyclohexene in aromatic solvents afforded the 
cor responding tetrahydroisoquinolines in yields less than 25%. 
The solvent-free procedure24 at the same ratio of reactants (ca. 
1: 5) and the temperature of 195–200 °C was significantly more 
effective: the target tetrahydroisoquinolines 2 were isolated in 
37–54% yields.† Note that all the products were simply purified 
by recrystallization and in most cases no column chromatography 
was needed.‡
Structures of products 2 were confirmed by spectral data. In 
addition, the crystal structures of compounds 2c and 2e were 
proved by X-ray diffraction analysis (Figure 1).§
The subsequent aromatization of products 2, for instance by 
the solvent-free heating over 10% Pd on carbon25 afforded iso-
quinolines 1 only in 10–15% yield, and a significant amount of 
oily by-products was detected in the reaction mixture. The proce-
dure using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in 
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Scheme 1 Reagents and conditions: i, 1-morpholinocyclohexene (neat), 
200 °C, 4 h; ii, DDQ, o-xylene, 143 °C, 10 h.
†
 Preparation of bipyridines 2 (general procedure). A mixture of the 
corresponding triazine 3 (2 mmol) and 1-morpholinocyclohexene (1.68 ml, 
10 mmol) was stirred at 200 °C for 2 h under argon. Then the additional 
portion of 1-morpholinocyclohexene (0.84 ml, 5 mmol) was added and 
the mixture was stirred for additional 2 h. The resulting solution was 
cooled to room temperature. Acetonitrile (20 ml) was added and the reac-
tion mixture was kept at –18 °C for 15 h. The fine crystalline precipitate 
formed was filtered off, washed with acetonitrile and dried. Analytically 
pure sample was obtained by recrystallization from acetonitrile.
 For characteristics of compounds 2a–e, see Online Supplementary 
Materials.
‡
 In case of bipyridine 2d column chromatography (CHCl3, Rf = 0.2) was 
used to purify the product.
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aromatic solvents was more successful. In a typical case refluxing 
of compounds 2 and 3 equiv. DDQ in o-xylene afforded iso-
quinolines 1 in yields up to 68%.¶
It should be mentioned that although the synthesis of com-
pound 1d was reported previously by R. Ziessel and co-authors,26 
their spectral data differed from those observed by us. In particular, 
in the 13C NMR spectrum of compound 1d obtained by us, the 
resonances of all 18 aromatic carbons are revealed versus 15 
carbon atoms reported by R. Ziessel and co-authors. In addition, 
its 1H NMR spectrum contained the charac teristic resonance for 
C4H proton of isoquinoline system as one proton singlet at 8.15 
ppm and several multiplets for other protons versus broad 
multiplet reported for this compound.26
Thus, we have developed an efficient and novel syn thetic route 
to aryl-substituted 1-(2-pyridyl)isoquinolines via the cor respond-
ing tetrahydroisoquinolines readily accessed from 1,2,4-triazines 
by the aza-Diels–Alder reaction. This approach allows one to 
obtain isoquinolines with a fairly wide variation of substituents 
in core.
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Molecular structures of bipyridines Figure 1 2c and 2e. Hydrogen atoms 
in 2e are omitted for clarity.
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 Crystal data for 2c. Brown crystals (0.33 × 0.18 × 0.03 mm), triclinic, 
space group P1–, at 150(2) K: a = 8.6964(7), b = 13.8034(11) and c = 
= 15.4544(19) Å, a = 112.724(11)°, b = 99.166(10)°, g = 103.960(7)°, 
V = 1593.2(3) Å3, Z = 4, dcalc = 1.523 g cm–3. 9057 reflections were 
collected (2.67° < q < 28.29°), 7639 independent (Rint = 0.0261) and 4429 
with I > 2s(I). Analytical correction for absorption was applied ( m = 
= 2.581 mm–1).27 The final refinement parameters were: R1 = 0.0408, 
wR2 = 0.0874 for reflections with I > 2s(I); R1 = 0.0839, wR2 = 0.0919 
for all reflections; GOF = 1.005. 
 Crystal data for 2e. Colourless crystals (0.25 × 0.20 × 0.15 mm), mono-
clinic, P21/c, at 295(2) K: a = 9.9141(12), b = 10.5438(7) and c = 
= 18.7699(17) Å, b = 99.358(9)°, V = 1935.9(3) Å3, Z = 4, dcalc = 1.244 g cm–3. 
8513 reflections were collected (2.777° < q < 28.28°), 4594 independent 
(Rint = 0.0309) and 1750 with I > 2s(I). Analytical correction for absorp-
tion was not applied ( m = 0.073 mm–1).27 The final refinement parameters 
were: R1 = 0.0429, wR2 = 0.079 for reflections with I > 2s(I); R1 = 0.1312, 
wR2 = 0.0852 for all reflections; GOF = 1.002.
 The structures were solved by direct methods and refined by full-matrix 
least-squares procedure on F2 with the SHELXTL-9728 program in the 
anisotropic approximation for non-hydrogen atoms. The positions of the 
H atoms were calculated geometrically and included in the refinement 
with the ‘riding model’.
 CCDC 913339 and 913340 contain the supplementary crystallographic data 
for this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
For details, see ‘Notice to Authors’, Mendeleev Commun., Issue 1, 2013.
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 Preparation of isoquinolines 1 (general procedure). A mixture of the 
corresponding bipyridine 2 (0.5 mmol), DDQ (114 mg, 0.5 mmol) and 
o-xylene (40 ml) was refluxed for 3 h. Additional portion of DDQ (114 mg, 
0.5 mmol) was added and the reaction mixture was refluxed for additional 
3 h. Then the final portion of DDQ (114 mg, 0.5 mmol) was added and 
the resulting mixture was refluxed for 4 h. The solvent was removed under 
reduced pressure, the residue was purified by column chromatography 
(neutral Al2O3, chloroform).
 For characteristics of compounds 1a–e, see Online Supplementary 
Materials.
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